Asproni Battistina, Pinna Gérard A, Corona Paola, Coinu Silvia, Piras Sandra, Carta Antonio, Murineddu Gabriele
Department of Medicine, Surgery and Pharmacy, University of Sassari, Via Muroni 23/A, 07100 Sassari, Italy.
Int J Mol Sci. 2025 Apr 17;26(8):3806. doi: 10.3390/ijms26083806.
Pyridazin-3(2)one-based molecules have always attracted the attention of medicinal chemists due to their different pharmacological properties. The incorporation of such nuclei in therapeutically active molecules either as monocyclic units or as fused bi- or tricyclic scaffolds results in a wide range of pharmacological effects such as anti-inflammatory, analgesic, anticancer, antimicrobial, antiviral, cardiovascular-protective, antiulcer, and many other useful pharmacological activities. In accordance with our consolidated experience gained over the years in the chemistry and biology of tricyclic pyridazin-3(2)ones, this review summarizes SAR studies of such pyridazinone-based polycyclic compounds endowed with various biological and therapeutic properties.
哒嗪 -3(2) 酮类分子因其不同的药理性质一直吸引着药物化学家的关注。将此类核心结构作为单环单元或稠合的双环或三环支架引入到具有治疗活性的分子中,会产生广泛的药理作用,如抗炎、镇痛、抗癌、抗菌、抗病毒、心血管保护、抗溃疡以及许多其他有用的药理活性。根据我们多年来在三环哒嗪 -3(2) 酮的化学和生物学方面积累的经验,本综述总结了此类具有各种生物学和治疗特性的基于哒嗪酮的多环化合物的构效关系研究。